Sort
82,697 grants matching “vaccine development”
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials
$923,551Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2018 · AI
High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
$923,143Ross S Chambers · Integral Molecular · R44 · FY2025 · GM
Novel Targets for Vaccine Therapy
$923,127Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Development of the first HRV vaccine
$923,094Gregory John Tobin · Biological Mimetics, Inc. · R44 · FY2014 · AI
CELL BIOLOGY OF MYCOBACTERIUM AVIUM INFECTION
$922,886University Of California San Francisco · P01 · FY2002 · AI
A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis
$922,693Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · AI
PEDIATRIC AIDS CLINICAL TRIALS GROUP
$922,683University Of California San Diego · U01 · FY2001 · AI
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
$922,642Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2016 · CA
Malaria Parasite Ligands And Host Cell Receptors
$922,609Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.
$922,525Sunnie Yoh · Scripps Research Institute, The · R01 · FY2023 · AI
Maximizing germinal centers and somatic hypermutation to HIV Env immunogens
$922,142Shane P Crotty · La Jolla Institute For Immunology · R37 · FY2021 · AI
Immunoprevention and immunosurveillance of human non-viral cancers
$922,006Olivera J Finn · University Of Pittsburgh At Pittsburgh · R35 · FY2017 · CA
Non-Human Primate Core
$921,983Norman L Letvin · Duke University · U19 · FY2008 · AI
Task A38: Establishment of Small Animal Models for Screening MCMs for the 2019 Novel Coronavirus (2019-nCoV)
$921,951Bart Tarbet · Utah State University · N01 · FY2020 · AI
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$921,938Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2020 · AI
structural characterization of iron uptake from human transferrin
$921,796Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Critical Path Project: Mapp66, a Multi-antibody Prevention Product
$921,571Kevin John Whaley · Boston University Medical Campus · U19 · FY2011 · AI
Biocontainment Research Support Service(s) Core
$921,558Rachel M Olson · University Of Missouri-Columbia · UC7 · FY2024 · AI
Shigella Live Vector-Based Multivalent Vaccine
$921,494Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2016 · AI
Wisconsin National Primate Research Center Support
$921,484Martin Cadwallader · University Of Wisconsin-Madison · P51 · FY2009 · RR
Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis
$921,475Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA
$921,373Margie Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2024 · CA
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$921,365Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AI
Marburg Vaccine Development
$921,308Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Project 3 - Flavivirus - UTMB
$921,136Pei-Yong Shi · University Of Alabama At Birmingham · U19 · FY2020 · AI